Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
A Study Comparing Nipocalimab and Efgartigimod for Adults with Generalized Myasthenia Gravis
AustriaA study testing how inebilizumab works and how safe it is in children and teenagers aged 2 to 17 years with generalized myasthenia gravis
FranceStudy of abatacept, tocilizumab, and tofacitinib compared to a second TNF inhibitor for children with juvenile idiopathic arthritis who did not respond to TNF inhibitor treatment
GermanyA study to test if empasiprubart can improve function and is safe for adults with chronic inflammatory demyelinating polyneuropathy
AustriaA Study of Anifrolumab for Patients with Cutaneous Lupus Erythematosus to Measure Changes in Skin and Blood Inflammation and Clinical Outcomes
AustriaA study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis
FranceAustriaStudy of icotrokinra for adults with moderately to severely active Crohn's disease
BelgiumTesting icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis
BelgiumA Study of Belumosudil for Patients with Steroid-Resistant Overlap Syndrome Graft-versus-Host Disease
GermanyA study testing VH4524184 with emtricitabine and tenofovir alafenamide compared to dolutegravir and lamivudine in adults with HIV-1 who have not received treatment before
BelgiumA study testing how well mirikizumab works to achieve transmural healing in patients with Crohn's Disease
FranceThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
